Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H3 | Q13133 | 6/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17640505 | 1.00 | NR1H3 (0.48) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17640385 | 0.99 | NR1H3 (0.49) | NR1H3NR1H2NPC1RAB9A | |
| SCHEMBL17640516 | 0.99 | NR1H3 (0.46) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17640398 | 0.99 | NR1H3 (0.49) | NR1H3NR1H2NPC1RAB9A | |
| SCHEMBL17640413 | 0.97 | NR1H3 (0.47) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19499722 | 0.96 | NR1H3 (0.45) | NR1H3NR1H2NPC1RAB9A | |
| SCHEMBL17640491 | 0.90 | SMN1; SMN2 (0.48) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19499729 | 0.90 | SMN1; SMN2 (0.48) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17640391 | 0.90 | SMN1; SMN2 (0.48) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17640503 | 0.90 | SMN1; SMN2 (0.48) | NR1H3NR1H2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | UDC IRELAND LIMITED (IE) | 2019-06-25 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| WO-2016046350-A1 | FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | NR2E3, CRY1, ALDH1A2 | NR1H3 1274/4885NR1H2 1878/4885NPC1 4857/4885 |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | NR2E3, CRY1, ALDH1A2 | NR1H3 1274/4885NR1H2 1878/4885NPC1 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.